Insights
Market Access, explained plainly.
Short articles, frameworks and career guidance. Enough to see the quality of thinking behind MEAXS, and useful on their own.
Why Market Access Strategy Should Start Before Registration
By the time a medicine is registered, many decisions that shape access are already fixed.
ReadNever Assume an Access Problem Is a Pricing Problem
Price is the most visible lever, so it gets blamed first. It is often the wrong diagnosis.
ReadThe Difference Between Budget Impact and Cost Effectiveness
Two questions every payer asks, and why a good answer to one does not answer the other.
ReadWhat Does a Payer Actually Want to Know?
Fewer questions than you think, and none of them are about your brand messages.
ReadHow Patient Flow Changes Your Access Strategy
Follow one patient through the system and your priorities will change.
ReadWhat Makes a Strong Market Access Professional?
Knowing the terminology is the starting line. These habits are what set people apart.
Read